Discontinuation of reflex testing of stool samples for vancomycin-resistant enterococci resulted in increased prevalence

Infection Control and Hospital Epidemiology

Volumn 34, Issue 8, 2013, Pages 838-840

  Bodily, Mandy ^a   McMullen, Kathleen M ^a   Russo, Anthony J ^a   Kittur, Nupur D ^b   Hoppe Bauer, Joan ^a   Warren, David K ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIURIA; CLOSTRIDIUM DIFFICILE; COST BENEFIT ANALYSIS; ENTEROCOCCAL INFECTION; FECES ANALYSIS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BACTERIURIA; COST-BENEFIT ANALYSIS; CROSS INFECTION; ENTEROCOCCUS; FECES; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; PREVALENCE; VANCOMYCIN RESISTANCE;

EID: 84880054758     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671276     Document Type: Article

References (11)

1. Butler A, Olsen M, Merz L, Guth R, Woeltje K, Camins B, Fraser V. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol 2010;31(1):28-35.
2. Garbutt J, Littenberg B, Evanoff B, Sahm D, Mundy L. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile. Infect Control Hosp Epidemiol 1999;20(10):664-670.
3. Ray A, Hoyen C, Das S, Eckstein E, Donskey C. Undetected vancomycin-resistant enterococcus stool colonization in a Veterans Affairs hospital using a Clostridium difficile-focused surveillance strategy. Infect Control Hosp Epidemiol 2002;23(8):474-477.
4. Burger T, Fry D, Fusco R, et al. Multihospitals surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and Clostridium difficile: analysis of a 4-year data sharing project, 1999-2002. Am J Infect Control 2006;34(7):458-454.
5. Sheetz M, Knechtel SA, Malczynski M, Postelnick MJ, Qi C. Increasing incidence of linezolid-intermediate or-resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008; 52(6):2256-2259.
6. Ajao A, Harris A, Roghman M, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycinresistant Enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol 2011;32(5):481-489.
7. Wagner A, Soumerai S, Zhang F, Ross-Dengan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002:27(4):299-309.
8. Muto C, Jernigan J, Ostrowsky B, et al. SHEA guideline for preventing nosocomial transmission of multi-drug resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24(5):362-386.
9. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multi drug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007;35(10)(suppl):S65-S194.
10. Calfee D, Gianetta E, Durbin L, Germanson T, Farr B. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003:37(3):326-332.
11. Lucet JC, Armand-Lefevre L, Laurichesse JJ, et al. Rapid control of an outbreak of vancomycin-resistance Enterococci in a French university hospital. J Hosp Infect 2007;67(1):42-48.